Evidence map›Paper›PMID 34671125›Full record

ArticleBritish journal of cancer2021

Diverse 'just-right' levels of chromosomal instability and their clinical implications in neoadjuvant treated gastric cancer.

Meike Kohlruss, Marie Krenauer, Bianca Grosser, Nicole Pfarr, Moritz Jesinghaus, Julia Slotta-Huspenina, Alexander Novotny, Alexander Hapfelmeier, Thomas Schmidt, Katja Steiger and 6 more

Open access · hybridAbstract read
In one paragraph

Article in British journal of cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. The reckoning of chromosomal instability: past, present, future.Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology · 2024
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 1 country.

Meike KohlrussInstitute of Pathology, TUM School of Medicine, Technical University of Munich, Munich, Germany.
Marie KrenauerInstitute of Pathology, TUM School of Medicine, Technical University of Munich, Munich, Germany.
Bianca GrosserInstitute of Pathology, TUM School of Medicine, Technical University of Munich, Munich, Germany.
Nicole PfarrInstitute of Pathology, TUM School of Medicine, Technical University of Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-5977-5375
Moritz JesinghausInstitute of Pathology, TUM School of Medicine, Technical University of Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-0018-5661
Julia Slotta-HuspeninaInstitute of Pathology, TUM School of Medicine, Technical University of Munich, Munich, Germany.
Alexander NovotnyDepartment of Surgery, TUM School of Medicine, Technical University of Munich, Munich, Germany.
Alexander HapfelmeierInstitute of Medical Informatics, Statistics and Epidemiology, Technical University of Munich, Munich, Germany.
Thomas SchmidtDepartment of Surgery, University of Heidelberg, Heidelberg, Germany.
Katja SteigerInstitute of Pathology, TUM School of Medicine, Technical University of Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-7269-5433
Matthias M GaidaInstitute of Pathology, University of Heidelberg, Heidelberg, Germany.
Magdalena ReicheInstitute of Pathology, TUM School of Medicine, Technical University of Munich, Munich, Germany.
Lukas BauerInstitute of Pathology, TUM School of Medicine, Technical University of Munich, Munich, Germany.
Katja OttDepartment of Surgery, RoMed Klinikum Rosenheim, Rosenheim, Germany.
Wilko WeichertInstitute of Pathology, TUM School of Medicine, Technical University of Munich, Munich, Germany.
Gisela KellerInstitute of Pathology, TUM School of Medicine, Technical University of Munich, Munich, Germany. gisela.keller@tum.de.ORCID http://orcid.org/0000-0003-2886-0371
Technical University of Munich · DEGerman Cancer Research Center · DEHeidelberg University · DEJohannes Gutenberg University Mainz · DEPhilipps University of Marburg · DERoMed Kliniken · DEUniversity Hospital Augsburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Cancer Genome Atlas (TCGA) consortium described EBV positivity(+), high microsatellite instability (MSI-H), genomic stability (GS) and chromosomal instability (CIN) as molecular subtypes in gastric carcinomas (GC). We investigated the predictive and prognostic value of these subtypes with emphasis on CIN in the context of neoadjuvant chemotherapy (CTx) in GC.

methodsTCGA subgroups were determined for 612 resected adenocarcinomas of the stomach and gastro-oesophageal junction (291 without, 321 with CTx) and 143 biopsies before CTx. EBV and MSI-H were analysed by standard assays. CIN was detected by multiplex PCRs analysing 22 microsatellite markers. Besides the TCGA classification, CIN was divided into four CIN-subgroups: low, moderate, substantial, high. Mutation profiling was performed for 52 tumours by next-generation sequencing.

resultsEBV(+) (HR, 0.48; 95% CI, 0.23-1.02), MSI-H (HR, 0.56; 95% CI, 0.35-0.89) and GS (HR, 0.72; 95% CI, 0.45-1.13) were associated with increased survival compared to CIN in the resected tumours. Considering the extended CIN-classification, CIN-substantial was a negative prognostic factor in uni- and multivariable analysis in resected tumours with CTx (each p < 0.05). In biopsies before CTx, CIN-high predicted tumour regression (p = 0.026), but was not prognostically relevant.

conclusionA refined CIN classification reveals tumours with different biological characteristics and potential clinical implications.

Indexed as

AdultAgedAged, 80 and overChromosomal InstabilityFemaleHumansMaleMiddle AgedNeoadjuvant TherapyStomach Neoplasms

Identifiers

PMID34671125
PMCPMC8651679
OpenAlexW3207784531

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.